ALA 1.61% 15.3¢ arovella therapeutics limited

Ann: Board Changes, page-5

  1. 743 Posts.
    lightbulb Created with Sketch. 115
    Problems in industry bigger than directors IMHO

    Small guys with model of selling out to big pharma after phase 2 look too risky. Maybe big pharma have changed their model.
    IMU trying to change up model but not any traction yet.
    May have to wait till after Lithium boom has ended...
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.